{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:55:51Z","timestamp":1791856551468,"version":"4.3.4"},"reference-count":10,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>There are several new composite indices for assessing disease activity in psoriatic arthritis (PsA). Each may function as a disease state variable and a responder index. The aim of our study was to determine cutoffs for disease activity and response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Data from the Group for GRAPPA Composite Exercise (GRACE) study were used to develop cutoffs using a number of different approaches. Voting on choice of cutoff was undertaken at the 2013 GRAPPA Annual Meeting in Toronto, Ontario, Canada.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>After voting, results for cutoffs for low\/high disease activity for the Psoriatic ArthritiS Disease Activity Score (PASDAS), GRAppa Composite scorE (GRACE index), and Composite Psoriatic Disease Activity Index (CPDAI), respectively, were 3.2\/5.4, 2.3\/4.7, and 4\/8. The measurement error for each composite score was estimated at 0.8, 1, and 2 for PASDAS, GRACE, and CPDAI, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Response criteria for the new composite indices have been developed. These now require further validation and testing in other datasets.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.140172","type":"journal-article","created":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T11:18:07Z","timestamp":1401621487000},"page":"1212-1217","source":"Crossref","is-referenced-by-count":106,"title":["Composite Disease Activity and Responder Indices for Psoriatic Arthritis: A Report from the GRAPPA 2013 Meeting on Development of Cutoffs for Both Disease Activity States and Response"],"prefix":"10.3899","volume":"41","author":[{"given":"Phillip S.","family":"Helliwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2014,6,1]]},"reference":[{"key":"2018112909325340000_41.6.1212.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380602"},{"key":"2018112909325340000_41.6.1212.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390105"},{"key":"2018112909325340000_41.6.1212.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.051706"},{"key":"2018112909325340000_41.6.1212.4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.37939","article-title":"Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease","volume":"65","author":"Coates","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2018112909325340000_41.6.1212.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391210"},{"key":"2018112909325340000_41.6.1212.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201341"},{"key":"2018112909325340000_41.6.1212.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129379"},{"key":"2018112909325340000_41.6.1212.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.117945"},{"key":"2018112909325340000_41.6.1212.9","doi-asserted-by":"crossref","unstructured":"Helliwell PS Kavanaugh A . Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab. Arthritis Care Res 2013 (E-pub ahead of print).","DOI":"10.1136\/annrheumdis-2013-eular.2020"},{"issue":"Suppl 39","key":"2018112909325340000_41.6.1212.10","first-page":"S93","article-title":"The Disease Activity Score and the EULAR response criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.140172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:36:18Z","timestamp":1543516578000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.140172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,1]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.3899\/jrheum.140172"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.140172","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}